Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo
Lena Hansen, Meagan McMahon, Hannah L. Turner, Xueyong Zhu, Jackson S. Turner, Gabriel Ozorowski, Daniel Stadlbauer, Juha Vahokoski, Aaron J. Schmitz, Amena A. Rizk, Wafaa B. Alsoussi, Shirin Strohmeier, Wenli Yu, José Alberto Choreño-Parra, Luis Jiménez-Álvarez, Alfredo Cruz‐Lagunas, Joaquı́n Zúñiga, Philip A. Mudd, Rebecca Jane Cox, Ian A. Wilson, Andrew B. Ward, Ali H. Ellebedy, Florian Krammer
Topics & Concepts
BiologyMonoclonal antibodyIn vivoVirologyPandemicIn vitroVirusAntibodyMicrobiologyCoronavirus disease 2019 (COVID-19)ImmunologyInfectious disease (medical specialty)GeneticsMedicineDiseasePathologyInfluenza Virus Research StudiesSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiology